MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
Jiaofeng Huang,1,* Wenjuan Xue,2,* Mingfang Wang,1 Yinlian Wu,1 Medha Singh,3 Yueyong Zhu,1,4 Rahul Kumar,5 Su Lin1 1Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, People’s Republic of China;...
Saved in:
Main Authors: | Huang J, Xue W, Wang M, Wu Y, Singh M, Zhu Y, Kumar R, Lin S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d35b26b12fbc41f3b38e6c86900e9672 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
by: Fan Y, et al.
Published: (2021) -
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021) -
Serum Fibroblast Growth Factor 23 Level and Liver Fat Content in MAFLD: A Community-Based Cohort
by: Cao W, et al.
Published: (2021) -
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
by: Filip R, et al.
Published: (2018) -
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
by: Jorge Gutiérrez-Cuevas, et al.
Published: (2021)